Head-to-head · WeighScore
AVARA Rx vs Eden
By GLP-1 ScorecardUpdated
Score comparison
Eden has the higher recorded score — 81.6/100 to 62.8/100.
Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.
Before you choose
Before comparing the headline prices, the AVARA Rx review and the Eden review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, AVARA Rx vs Effecty and BiltRx vs Eden compare each of them with another graded program, and the list of alternatives to AVARA Rx ranks the programs closest to AVARA Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AVARA Rx | Eden |
|---|---|---|
| WeighScore | 62.8/100 | 81.6/100 |
| Grade | C | B− |
| Site position | #285 | #16 |
| Semaglutide | Personalized "GLP-1" (drug not named) starting at $229 | Advertised $99/mo bundle; linked membership terms conflict—confirm checkout |
| Tirzepatide | Personalized "GLP-1/GIP" (drug not named) starting at $279 | Advertised $129/mo bundle; linked membership terms conflict—confirm checkout |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Names its pharmacy partner (DiRx Health, Ft Lauderdale FL) — buyers can independently verify its licensure
- Names its clinical network (Beluga Health) — you can research the platform handling your prescriptions
- All 50 states explicitly listed on the FAQ — uncommon vs peers that just say 'nationwide'
- Patient-friendly refunds — full refund if a provider disqualifies you, partial if a weaker dose is prescribed
- LegitScript verification badge displayed; pharmacy claims NABP-accredited facilities
What to consider
- Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
- Dose pricing not itemized — only 'starting at $229' for GLP-1 and 'starting at $279' for GLP-1/GIP, without naming either drug
- LegitScript certification number not shown — badge only, so no direct lookup
- No named medical director (Beluga Health is the network, not a named MD)
- Lab work requirements not specified, and consultation fee not broken out from medication cost
Site position #16 · B−
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Strengths
- Current compounded offer includes medication and support
- Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
- Named pharmacy operation and partner network can be investigated
What to consider
- Linked membership terms describe a separate fee model
- Landing-page warranty and terms use different thresholds and conditions
- FDA warning history remains relevant; a new offer does not establish resolution
Featured provider
Eden
Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.